1. Home
  2. BCG vs NMTC Comparison

BCG vs NMTC Comparison

Compare BCG & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BCG

Binah Capital Group Inc.

HOLD

Current Price

$2.05

Market Cap

39.8M

Sector

N/A

ML Signal

HOLD

Logo NeuroOne Medical Technologies Corporation

NMTC

NeuroOne Medical Technologies Corporation

HOLD

Current Price

$0.83

Market Cap

43.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCG
NMTC
Founded
2016
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.8M
43.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BCG
NMTC
Price
$2.05
$0.83
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$2.23
AVG Volume (30 Days)
10.0K
237.3K
Earning Date
03-30-2026
02-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.04
N/A
Revenue
$178,203,000.00
$12,097,692.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$32.08
P/E Ratio
$58.30
N/A
Revenue Growth
10.19
250.35
52 Week Low
$1.36
$0.40
52 Week High
$5.81
$1.25

Technical Indicators

Market Signals
Indicator
BCG
NMTC
Relative Strength Index (RSI) 38.55 44.33
Support Level $2.26 $0.75
Resistance Level $2.45 $0.86
Average True Range (ATR) 0.14 0.06
MACD -0.04 -0.01
Stochastic Oscillator 0.00 27.17

Price Performance

Historical Comparison
BCG
NMTC

About BCG Binah Capital Group Inc.

Binah Capital Group Inc formerly Wentworth Management Services LLC is a holding company that acquires and manages businesses in the wealth management industry. The company specializes in consolidating independent broker-dealers to capture economies of scale needed to service financial advisors in today's technology-enabled regulatory environment. Wentworth's core philosophy focuses on building long-term, productive relationships with its advisor base.

About NMTC NeuroOne Medical Technologies Corporation

NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.

Share on Social Networks: